EP4371611
REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
11.8.2017EP published:
17.6.2026EP application number:
24166956.3
EPO information:
European Patent Register
Max expiry date:
10.8.2037Expiry date:
16.10.2026
Title in English:
REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMABLanguage of the patent:
English
Timeline
Today
11.8.2017EP application
17.6.2026EP Publication
16.10.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
WALLSTRÖM, ErikAddress:
4002 Basel, CH
Name:
SAVELIEVA PRAZ, MarinaAddress:
4002 Basel, CH
Name:
KAKARIEKA WEISSKOPF, Algirdas JonasAddress:
4002 Basel, CH
Name:
KAHN, Joseph MichaelAddress:
East Hanover, NJ 07936-1080, US
Priority
Number:
201662374986 PDate:
15.8.2016Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395, A61P 25/28, A61P 37/06